The dispute "European Communities - Protection of trademarks and geographical indications for agricultural products and foodstuffs" that opposes the European - Union to the United States and Australia, has been raised by the European regulation concerning the protection of geographical...

This article tells the story about how a private international firm, based in the United States, achieved the domination of a discussed kind of product, a genetically modified soya seed, on developing countries markets, especially Brazil, in violation of both Brazilian domestic law and Brazilian...

In “The right to good ideas: patents and the poor”, The Economist depicts two driving forces in the contemporary discourse on IP and globalization. The one is interested in advancing the knowledge economy, an approach based on the belief that knowledge is the driving factor behind economic...

Intellectual property treaties have two main types of provisions: national treatment of foreign inventors, and harmonization of protections. I characterize the circumstances in which countries would want to treat foreign inventors the same as national inventors. I then argue that national...

The Agreement on Trade Related Aspects on Intellectual Property Rights, 1995, has introduced several mandatory changes to patent protection on pharmaceuticals that can affect health care and delivery in developing countries. The potential detrimental impacts of such IPR protection raise three...

This paper begins by surveying recent economic studies of the relationships between technology transfer, intellectual property, innovation and diffusion in emerging countries.  It applies this literature to the Indian case.  India  is a potentially useful case study for several reasons. ...

Building on the seminal work of Ginarte and Park (1997. Research Policy. 26, 283–301), we develop an index of property rights in pharmaceutical inventions, the Pharmaceutical Intellectual Property Protection (PIPP) Index, for 154 countries spanning 1960 to 2005. It incorporates five types of...

We use dynamic panel data regressions to investigate whether the strength of a country’s patent protection for pharmaceuticals is associated with more pharmaceutical patenting by its residents and corporations in the United States. Using the Pharmaceutical Intellectual Property Protection...

Building on the seminal work of Ginarte and Park (1997), we develop an index of property rights in pharmaceutical innovations, the Pharmaceutical Intellectual Property Protection (PIPP) Index, for 154 countries spanning 1960 to 2005. It incorporates 5 types of property rights in pharmaceuticals;...